{"entity":{"type":"insider","cik":"0001816196","url":"/insider/0001816196","json_url":"/insider/0001816196.json","name":"Detheux Michel","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":47,"n_filings":16,"first":"2021-06-16","last":"2025-06-11","span_basis":"filed_date"},"name_variants":[{"name":"Detheux Michel","source":"filing","n_filings":16,"first_seen":"2021-06-16","last_seen":"2025-06-11"}],"transactions":[{"id":4100734,"accession":"0000950170-25-085047","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000950170-25-085047","line_url":"/filing/0000950170-25-085047","is_derivative":false,"issuer_cik":"0001808865","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001808865","owner_cik":"0001816196","owner_name":"Detheux Michel","owner_display_name":"Detheux Michel","owner_url":"/insider/0001816196","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52283.0,"shares_display":"52,283","price_per_share":10.02,"price_display":"10.02","price_state":"stated","total_value":523875.66,"total_display":"523,875.66","total_whole":"523,876","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-10","filed_date":"2025-06-11","scope":"insider","n_lines":2},{"id":4100717,"accession":"0000950170-25-085047","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-25-085047","line_url":"/filing/0000950170-25-085047","is_derivative":false,"issuer_cik":"0001808865","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001808865","owner_cik":"0001816196","owner_name":"Detheux Michel","owner_display_name":"Detheux Michel","owner_url":"/insider/0001816196","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52282.0,"shares_display":"52,282","price_per_share":10.03,"price_display":"10.03","price_state":"stated","total_value":524388.46,"total_display":"524,388.46","total_whole":"524,388","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-09","filed_date":"2025-06-11","scope":"insider","n_lines":2},{"id":4618471,"accession":"0000950170-25-083411","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000950170-25-083411","line_url":"/filing/0000950170-25-083411","is_derivative":false,"issuer_cik":"0001808865","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001808865","owner_cik":"0001816196","owner_name":"Detheux Michel","owner_display_name":"Detheux Michel","owner_url":"/insider/0001816196","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52282.0,"shares_display":"52,282","price_per_share":10.21,"price_display":"10.21","price_state":"stated","total_value":533799.22,"total_display":"533,799.22","total_whole":"533,799","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-06","filed_date":"2025-06-06","scope":"insider","n_lines":2},{"id":4618437,"accession":"0000950170-25-083411","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000950170-25-083411","line_url":"/filing/0000950170-25-083411","is_derivative":false,"issuer_cik":"0001808865","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001808865","owner_cik":"0001816196","owner_name":"Detheux Michel","owner_display_name":"Detheux Michel","owner_url":"/insider/0001816196","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52282.0,"shares_display":"52,282","price_per_share":10.15,"price_display":"10.15","price_state":"stated","total_value":530662.3,"total_display":"530,662.30","total_whole":"530,662","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-05","filed_date":"2025-06-06","scope":"insider","n_lines":2},{"id":4618403,"accession":"0000950170-25-083411","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-25-083411","line_url":"/filing/0000950170-25-083411","is_derivative":false,"issuer_cik":"0001808865","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001808865","owner_cik":"0001816196","owner_name":"Detheux Michel","owner_display_name":"Detheux Michel","owner_url":"/insider/0001816196","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52283.0,"shares_display":"52,283","price_per_share":10.1,"price_display":"10.10","price_state":"stated","total_value":528058.3,"total_display":"528,058.30","total_whole":"528,058","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-04","filed_date":"2025-06-06","scope":"insider","n_lines":2},{"id":6273268,"accession":"0001209191-22-024859","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-024859","line_url":"/filing/0001209191-22-024859","is_derivative":false,"issuer_cik":"0001808865","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001808865","owner_cik":"0001816196","owner_name":"Detheux Michel","owner_display_name":"Detheux Michel","owner_url":"/insider/0001816196","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11500.0,"shares_display":"11,500","price_per_share":31.872209565217393,"price_display":"31.87","price_state":"stated","total_value":366530.41,"total_display":"366,530.41","total_whole":"366,530","shares_owned_after":26296.0,"shares_owned_after_display":"26,296","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-18","filed_date":"2022-04-19","scope":"insider","n_lines":2},{"id":6482180,"accession":"0001209191-22-020649","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-020649","line_url":"/filing/0001209191-22-020649","is_derivative":false,"issuer_cik":"0001808865","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001808865","owner_cik":"0001816196","owner_name":"Detheux Michel","owner_display_name":"Detheux Michel","owner_url":"/insider/0001816196","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18437.0,"shares_display":"18,437","price_per_share":34.16971416173998,"price_display":"34.17","price_state":"stated","total_value":629987.02,"total_display":"629,987.02","total_whole":"629,987","shares_owned_after":28970.0,"shares_owned_after_display":"28,970","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-22","filed_date":"2022-03-22","scope":"insider","n_lines":4},{"id":6424134,"accession":"0001209191-22-012880","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-012880","line_url":"/filing/0001209191-22-012880","is_derivative":false,"issuer_cik":"0001808865","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001808865","owner_cik":"0001816196","owner_name":"Detheux Michel","owner_display_name":"Detheux Michel","owner_url":"/insider/0001816196","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14500.0,"shares_display":"14,500","price_per_share":34.3382675862069,"price_display":"34.34","price_state":"stated","total_value":497904.88,"total_display":"497,904.88","total_whole":"497,905","shares_owned_after":35244.0,"shares_owned_after_display":"35,244","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-23","filed_date":"2022-02-24","scope":"insider","n_lines":2},{"id":6776772,"accession":"0001209191-22-005118","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-005118","line_url":"/filing/0001209191-22-005118","is_derivative":false,"issuer_cik":"0001808865","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001808865","owner_cik":"0001816196","owner_name":"Detheux Michel","owner_display_name":"Detheux Michel","owner_url":"/insider/0001816196","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14500.0,"shares_display":"14,500","price_per_share":35.681249655172415,"price_display":"35.68","price_state":"stated","total_value":517378.12,"total_display":"517,378.12","total_whole":"517,378","shares_owned_after":53612.0,"shares_owned_after_display":"53,612","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-25","filed_date":"2022-01-26","scope":"insider","n_lines":2},{"id":4106430,"accession":"0001209191-21-070996","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-21-070996","line_url":"/filing/0001209191-21-070996","is_derivative":false,"issuer_cik":"0001808865","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001808865","owner_cik":"0001816196","owner_name":"Detheux Michel","owner_display_name":"Detheux Michel","owner_url":"/insider/0001816196","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16163.0,"shares_display":"16,163","price_per_share":45.03422446328033,"price_display":"45.03","price_state":"stated","total_value":727888.17,"total_display":"727,888.17","total_whole":"727,888","shares_owned_after":63700.0,"shares_owned_after_display":"63,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-22","filed_date":"2021-12-22","scope":"insider","n_lines":4},{"id":4106408,"accession":"0001209191-21-070996","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-070996","line_url":"/filing/0001209191-21-070996","is_derivative":false,"issuer_cik":"0001808865","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001808865","owner_cik":"0001816196","owner_name":"Detheux Michel","owner_display_name":"Detheux Michel","owner_url":"/insider/0001816196","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19226.0,"shares_display":"19,226","price_per_share":44.41411109955269,"price_display":"44.41","price_state":"stated","total_value":853905.7,"total_display":"853,905.70","total_whole":"853,906","shares_owned_after":83780.0,"shares_owned_after_display":"83,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-21","filed_date":"2021-12-22","scope":"insider","n_lines":2},{"id":4106397,"accession":"0001209191-21-070996","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-070996","line_url":"/filing/0001209191-21-070996#line-2","is_derivative":false,"issuer_cik":"0001808865","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001808865","owner_cik":"0001816196","owner_name":"Detheux Michel","owner_display_name":"Detheux Michel","owner_url":"/insider/0001816196","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9111.0,"shares_display":"9,111","price_per_share":43.94,"price_display":"43.94","price_state":"stated","total_value":400337.34,"total_display":"400,337.34","total_whole":"400,337","shares_owned_after":78200.0,"shares_owned_after_display":"78,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-20","filed_date":"2021-12-22","scope":"insider"},{"id":5501242,"accession":"0001209191-21-066884","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-066884","line_url":"/filing/0001209191-21-066884#line-2","is_derivative":false,"issuer_cik":"0001808865","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001808865","owner_cik":"0001816196","owner_name":"Detheux Michel","owner_display_name":"Detheux Michel","owner_url":"/insider/0001816196","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14500.0,"shares_display":"14,500","price_per_share":36.08,"price_display":"36.08","price_state":"stated","total_value":523160.0,"total_display":"523,160.00","total_whole":"523,160","shares_owned_after":78200.0,"shares_owned_after_display":"78,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-23","filed_date":"2021-11-24","scope":"insider"},{"id":5406365,"accession":"0001209191-21-062843","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-062843","line_url":"/filing/0001209191-21-062843#line-3","is_derivative":false,"issuer_cik":"0001808865","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001808865","owner_cik":"0001816196","owner_name":"Detheux Michel","owner_display_name":"Detheux Michel","owner_url":"/insider/0001816196","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6085.0,"shares_display":"6,085","price_per_share":28.887,"price_display":"28.89","price_state":"stated","total_value":175777.395,"total_display":"175,777.40","total_whole":"175,777","shares_owned_after":76437.0,"shares_owned_after_display":"76,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-03","filed_date":"2021-11-03","scope":"insider"},{"id":5406361,"accession":"0001209191-21-062843","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-062843","line_url":"/filing/0001209191-21-062843#line-2","is_derivative":false,"issuer_cik":"0001808865","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001808865","owner_cik":"0001816196","owner_name":"Detheux Michel","owner_display_name":"Detheux Michel","owner_url":"/insider/0001816196","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14391.0,"shares_display":"14,391","price_per_share":28.415,"price_display":"28.42","price_state":"stated","total_value":408920.265,"total_display":"408,920.26","total_whole":"408,920","shares_owned_after":82522.0,"shares_owned_after_display":"82,522","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-02","filed_date":"2021-11-03","scope":"insider"},{"id":5406359,"accession":"0001209191-21-062843","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-062843","line_url":"/filing/0001209191-21-062843#line-1","is_derivative":false,"issuer_cik":"0001808865","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001808865","owner_cik":"0001816196","owner_name":"Detheux Michel","owner_display_name":"Detheux Michel","owner_url":"/insider/0001816196","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":81.0,"shares_display":"81","price_per_share":28.0,"price_display":"28.00","price_state":"stated","total_value":2268.0,"total_display":"2,268.00","total_whole":"2,268","shares_owned_after":96913.0,"shares_owned_after_display":"96,913","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-01","filed_date":"2021-11-03","scope":"insider"},{"id":4677014,"accession":"0001209191-21-061569","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-061569","line_url":"/filing/0001209191-21-061569#line-1","is_derivative":false,"issuer_cik":"0001808865","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001808865","owner_cik":"0001816196","owner_name":"Detheux Michel","owner_display_name":"Detheux Michel","owner_url":"/insider/0001816196","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":196.0,"shares_display":"196","price_per_share":28.0001,"price_display":"28.00","price_state":"stated","total_value":5488.0196,"total_display":"5,488.02","total_whole":"5,488","shares_owned_after":96994.0,"shares_owned_after_display":"96,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-21","filed_date":"2021-10-25","scope":"insider"},{"id":4487535,"accession":"0001209191-21-061042","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-061042","line_url":"/filing/0001209191-21-061042#line-2","is_derivative":false,"issuer_cik":"0001808865","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001808865","owner_cik":"0001816196","owner_name":"Detheux Michel","owner_display_name":"Detheux Michel","owner_url":"/insider/0001816196","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":201.0,"shares_display":"201","price_per_share":28.0,"price_display":"28.00","price_state":"stated","total_value":5628.0,"total_display":"5,628.00","total_whole":"5,628","shares_owned_after":97190.0,"shares_owned_after_display":"97,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-19","filed_date":"2021-10-19","scope":"insider"},{"id":4487525,"accession":"0001209191-21-061042","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-061042","line_url":"/filing/0001209191-21-061042#line-1","is_derivative":false,"issuer_cik":"0001808865","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001808865","owner_cik":"0001816196","owner_name":"Detheux Michel","owner_display_name":"Detheux Michel","owner_url":"/insider/0001816196","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1635.0,"shares_display":"1,635","price_per_share":28.01,"price_display":"28.01","price_state":"stated","total_value":45796.35,"total_display":"45,796.35","total_whole":"45,796","shares_owned_after":97391.0,"shares_owned_after_display":"97,391","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-15","filed_date":"2021-10-19","scope":"insider"},{"id":4587112,"accession":"0001209191-21-057850","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-057850","line_url":"/filing/0001209191-21-057850#line-2","is_derivative":false,"issuer_cik":"0001808865","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001808865","owner_cik":"0001816196","owner_name":"Detheux Michel","owner_display_name":"Detheux Michel","owner_url":"/insider/0001816196","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1089.0,"shares_display":"1,089","price_per_share":28.018,"price_display":"28.02","price_state":"stated","total_value":30511.602,"total_display":"30,511.60","total_whole":"30,512","shares_owned_after":99026.0,"shares_owned_after_display":"99,026","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-24","filed_date":"2021-09-27","scope":"insider"},{"id":4587107,"accession":"0001209191-21-057850","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-057850","line_url":"/filing/0001209191-21-057850#line-1","is_derivative":false,"issuer_cik":"0001808865","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001808865","owner_cik":"0001816196","owner_name":"Detheux Michel","owner_display_name":"Detheux Michel","owner_url":"/insider/0001816196","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5322.0,"shares_display":"5,322","price_per_share":28.159,"price_display":"28.16","price_state":"stated","total_value":149862.198,"total_display":"149,862.20","total_whole":"149,862","shares_owned_after":100115.0,"shares_owned_after_display":"100,115","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-23","filed_date":"2021-09-27","scope":"insider"},{"id":4538750,"accession":"0001209191-21-054904","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-054904","line_url":"/filing/0001209191-21-054904","is_derivative":false,"issuer_cik":"0001808865","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001808865","owner_cik":"0001816196","owner_name":"Detheux Michel","owner_display_name":"Detheux Michel","owner_url":"/insider/0001816196","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11568.0,"shares_display":"11,568","price_per_share":28.941528526970956,"price_display":"28.94","price_state":"stated","total_value":334795.602,"total_display":"334,795.60","total_whole":"334,796","shares_owned_after":105987.0,"shares_owned_after_display":"105,987","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-02","filed_date":"2021-09-03","scope":"insider","n_lines":2},{"id":4538742,"accession":"0001209191-21-054904","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-054904","line_url":"/filing/0001209191-21-054904#line-1","is_derivative":false,"issuer_cik":"0001808865","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001808865","owner_cik":"0001816196","owner_name":"Detheux Michel","owner_display_name":"Detheux Michel","owner_url":"/insider/0001816196","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8684.0,"shares_display":"8,684","price_per_share":28.296,"price_display":"28.30","price_state":"stated","total_value":245722.464,"total_display":"245,722.46","total_whole":"245,722","shares_owned_after":117005.0,"shares_owned_after_display":"117,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-01","filed_date":"2021-09-03","scope":"insider"},{"id":4675542,"accession":"0001209191-21-054169","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-054169","line_url":"/filing/0001209191-21-054169#line-3","is_derivative":false,"issuer_cik":"0001808865","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001808865","owner_cik":"0001816196","owner_name":"Detheux Michel","owner_display_name":"Detheux Michel","owner_url":"/insider/0001816196","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4093.0,"shares_display":"4,093","price_per_share":28.12,"price_display":"28.12","price_state":"stated","total_value":115095.16,"total_display":"115,095.16","total_whole":"115,095","shares_owned_after":125689.0,"shares_owned_after_display":"125,689","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-31","filed_date":"2021-08-31","scope":"insider"},{"id":4675537,"accession":"0001209191-21-054169","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-054169","line_url":"/filing/0001209191-21-054169#line-2","is_derivative":false,"issuer_cik":"0001808865","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001808865","owner_cik":"0001816196","owner_name":"Detheux Michel","owner_display_name":"Detheux Michel","owner_url":"/insider/0001816196","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2322.0,"shares_display":"2,322","price_per_share":28.01,"price_display":"28.01","price_state":"stated","total_value":65039.22,"total_display":"65,039.22","total_whole":"65,039","shares_owned_after":129782.0,"shares_owned_after_display":"129,782","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-30","filed_date":"2021-08-31","scope":"insider"},{"id":4675531,"accession":"0001209191-21-054169","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-054169","line_url":"/filing/0001209191-21-054169#line-1","is_derivative":false,"issuer_cik":"0001808865","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001808865","owner_cik":"0001816196","owner_name":"Detheux Michel","owner_display_name":"Detheux Michel","owner_url":"/insider/0001816196","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8248.0,"shares_display":"8,248","price_per_share":28.17,"price_display":"28.17","price_state":"stated","total_value":232346.16,"total_display":"232,346.16","total_whole":"232,346","shares_owned_after":132104.0,"shares_owned_after_display":"132,104","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-27","filed_date":"2021-08-31","scope":"insider"},{"id":4230226,"accession":"0001209191-21-053381","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-053381","line_url":"/filing/0001209191-21-053381#line-3","is_derivative":false,"issuer_cik":"0001808865","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001808865","owner_cik":"0001816196","owner_name":"Detheux Michel","owner_display_name":"Detheux Michel","owner_url":"/insider/0001816196","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":861.0,"shares_display":"861","price_per_share":28.0013,"price_display":"28.00","price_state":"stated","total_value":24109.1193,"total_display":"24,109.12","total_whole":"24,109","shares_owned_after":140352.0,"shares_owned_after_display":"140,352","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-25","filed_date":"2021-08-25","scope":"insider"},{"id":4230221,"accession":"0001209191-21-053381","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-053381","line_url":"/filing/0001209191-21-053381#line-2","is_derivative":false,"issuer_cik":"0001808865","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001808865","owner_cik":"0001816196","owner_name":"Detheux Michel","owner_display_name":"Detheux Michel","owner_url":"/insider/0001816196","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":225.0,"shares_display":"225","price_per_share":28.26,"price_display":"28.26","price_state":"stated","total_value":6358.5,"total_display":"6,358.50","total_whole":"6,359","shares_owned_after":141213.0,"shares_owned_after_display":"141,213","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-24","filed_date":"2021-08-25","scope":"insider"},{"id":4230215,"accession":"0001209191-21-053381","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-053381","line_url":"/filing/0001209191-21-053381#line-1","is_derivative":false,"issuer_cik":"0001808865","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001808865","owner_cik":"0001816196","owner_name":"Detheux Michel","owner_display_name":"Detheux Michel","owner_url":"/insider/0001816196","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7499.0,"shares_display":"7,499","price_per_share":28.06,"price_display":"28.06","price_state":"stated","total_value":210421.94,"total_display":"210,421.94","total_whole":"210,422","shares_owned_after":141438.0,"shares_owned_after_display":"141,438","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-23","filed_date":"2021-08-25","scope":"insider"},{"id":4812547,"accession":"0000899243-21-024238","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-024238","line_url":"/filing/0000899243-21-024238","is_derivative":false,"issuer_cik":"0001808865","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001808865","owner_cik":"0001816196","owner_name":"Detheux Michel","owner_display_name":"Detheux Michel","owner_url":"/insider/0001816196","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29000.0,"shares_display":"29,000","price_per_share":28.50117752413793,"price_display":"28.50","price_state":"stated","total_value":826534.1482,"total_display":"826,534.15","total_whole":"826,534","shares_owned_after":152874.0,"shares_owned_after_display":"152,874","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-14","filed_date":"2021-06-16","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":47,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":47,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":47},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001808865","name":"iTeos Therapeutics, Inc.","url":"/issuer/0001808865","role":"Director, Officer (Chief Executive Officer)","n_filings":16,"first_seen":"2021-06-16","last_seen":"2025-06-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001816196","retrieved_at":"2026-08-25T06:06:17+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}